Anti-obesity drug - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Anti-obesity drug


  
 Anti-obesity drug - Wikipedia, the free encyclopedia
Orlistat may be a better choice for obese patients with conditions that might be aggravated by stimulants.
Because of this, anti-obesity drugs are not a practical long-term solution for people who are overweight.
One such drug in development is Rimonabant from Sanofi-Aventis, it is designed to block the effects of endogenous cannabinoids.
http://en.wikipedia.org/wiki/Anti-obesity_drug   (569 words)

  
 Obesity Treatment: The Long-term and Short-term Efficacy and Safety of Anti-obesity Drugs (Page2.html)
Drug therapy is the most effective means of achieving such manipulations.
The Food and Drug Administration in the August 6, 1997, edition of the Journal of American Medical Association stated that as of early July, there were 33 cases of heart valve disease associated with phen/fen that had been reported and were mostly multivalvular conditions (Nightingale 1997).
The biochemical compositions of each drug are not very similar with the exception of dexfenfluramine, which is simply the dextro-enantiomer of fenfluramine (Bray 1995).
http://medweb.pc.edu/students/med2002/drake1/Page2.html   (3313 words)

  
 The pros and cons of new anti-obesity drug
However despite speculation that the drug could become the world’s first blockbuster anti-obesity medicine, given the continued concern voiced by respected doctors and researchers not directly involved with the clinical trials of Acomplia (rimonabant), FDA approval could well be delayed.
After a two-year study period, the researchers say the drug Acomplia, or rimonabant needs more research into its long-term effects as the study was limited by a high dropout rate.
The drug company Sanofi-Aventis funded the study and is now waiting for approval by the U.S. Food and Drug Administration (FDA).
http://www.health.am/weightloss/more/the_pros_and_cons_of_new_anti_obesity_drug   (624 words)

  
 Anti Obesity Drugs Online Resources
Anti-obesity drugs are designed to be part of comprehensive weight-loss a new class of anti-obesity drugs that works by blocking the.
The limitations of available anti-obesity drugs and the lack of sufficient cooperation from patients categories of prescription anti-obesity drugs: anti-satiety and anti-absorptive.
The limitations of available anti-obesity drugs and the lack of both categories of prescription anti-obesity drugs: anti-satiety and anti-absorptive.
http://www.weightloss-supplements.org/w5/anti_obesity_drugs.html   (488 words)

  
 Amy Guttenberger
Drug producers found that increasing the area of the market would help increase sales, interest and awareness of the drugs.
As with any newly developed drug on the market, producers must powerfully introduce and highlight the many perks of their product to the health providers and consumers.
  This catalyzes the anti-obesity drug research and in turn can lead to new drug developments sooner.
http://www.msu.edu/~guttende/atl/revie2.html   (767 words)

  
 World Emerging Anti-Obesity Prescription Drug Markets
The study analyzes the existing treatment options for obesity and the emerging anti-obesity drugs that are under advanced stages of development.
The drugs that are currently available are unable to penetrate the market due to their side-effects profile.
One of the reasons for the sluggish growth of the anti-obesity prescription drugs market has been the products themselves, as they have failed to meet customer expectations and side-effect profiles.
http://www.frost.com/prod/servlet/report-brochure.pag?id=A643-01-00-00-00   (1097 words)

  
 The role of new anti-obesity drug orlistat in gene
Overseas experience has shown that patient demand for orlistat is high and GPs need to be aware of the uses of this drug in clinical practice and be prepared to answer questions from their patients.
The role of new anti-obesity drug orlistat in general practice
The drug when released in Australia will come with a support program via a 1800 phone number with trained dietitians, exercise physiologists and psychologists plus written material and that may improve on the above results.
http://www.medicineau.net.au/clinical/obesity/obesit1276.html   (1310 words)

  
 Salient uses of the anti-obesity drug Meridia: Always-Health.com
As for the particular category of individuals for which the drug Meridia is prescribed, it must be noted that this drug is not for everybody who has some desires for loosing some weight, such as its cosmetic application.
Salient uses of the anti-obesity drug Meridia: Always-Health.com
Another notable aspect about the category of Meridia, to which it belongs namely the neurotransmitter repute inhibitors, is that similar drugs have been in usage for a number of years in the form of depressants such as Prozac as just one example.
http://www.always-health.com/Meridia3.html   (354 words)

  
 Quest for blockbuster obesity drug vexes firms
The view that some obese people could benefit from certain drugs -- going beyond changes in exercise and eating habits -- must be embraced by the medical profession and patients alike, they say.
While a drug may help obese rodents lose weight, there is no guarantee it will work on humans, he said, and a breakthrough in this area is not very likely for at least another 18 months.
Roche's experience with Xenical was disappointing after a year of heady growth and great expectations for the drug, whose US launch was in April 1999, according to analysts.
http://www.personalmd.com/news/n0817095106.shtml   (1112 words)

  
 Heart Problems With Anti-Obesity Drug, Dexfenfluramine, Appear Mild And Reversible
Shively says there was no relationship in this study between the amount of time a patient took the diet drug and their risk of heart valve problems.
DALLAS, TX -- November 23, 1999 -- More evidence has been found linking the anti-obesity drug dexfenfluramine with damage to heart valves but the new research suggests that the problems are typically not severe and may regress after the drug is discontinued, according to Circulation: Journal of the American Heart Association.
The chances of detecting a valve problem were related to the length of time from drug cessation.
http://www.pslgroup.com/dg/149c22.htm   (721 words)

  
 Anti-Obesity diet drug from cannabis works!
Drug therapy, he says is the answer for certain obese patients who are at risk.
According to analysts there are now 26 new drugs in clinical trials for obesity and a further 32 in the pipeline.
Would you like to register for our weekly NO-NONSENSE Medical News Letter?
http://www.news-medical.net/?id=15421   (991 words)

  
 Business Wire: Anti-Obesity Drug Manufacturers Focus on Long-T... @ HighBeam Research
Roche has positioned Xenical as a drug for a serious medical problem and has targeted their promotion campaign towards primary care physicians, managed-care officials, and women, who would be the most likely group to take anti-obesity drugs.
Yet in the anti-obesity market, current drugs are only palliative.
Consequently, interest in anti-obesity drugs continues to grow.
http://www.highbeam.com/library/doc0.asp?docid=1G1:59108442&refid=ink_tptd_np   (813 words)

  
 Xenical media references
Generic Drugs: Generic Drugs an optimum alternative to lower out...
However, while the results are striking they do not 'stand out' especially as they are similar to the drugs Xenical (Orlistat) by Roche and Abbbot’s Meridia.
Other prescription drugs illegally distributed and dispensed included Viagra, Xenical, Propecia, and Celebrex.
http://bluegrouper.com/drugs/2004/Xenical.html   (1504 words)

  
 Metabolic to add weight to anti-obesity drug - Business - www.theage.com.au
Metabolic seems to be taking a more pragmatic approach to its development plans for the drug.
With Dr Scollay at the helm after Dr Belyea's resignation, Metabolic seems to be taking a more pragmatic approach to its development plans for the drug, code-named AOD9604.
And if it's successful it will add a lot of value to the drug."
http://www.theage.com.au/news/Business/Metabolic-to-add-weight-to-antiobesity-drug/2005/03/07/1110160752968.html   (618 words)

  
 Body Empowerment United
Abbott, which markets the drug as Meridia in the United States, has said that 8.6 million people have used sibutramine-based drugs since 1997 and that it is not aware of any substantial change to the drug's risk-benefit profile.
Italy suspended sales last week after reports of health problems including two fatalities, but the UK department said that patients "can continue to take their medicines."
However, if they are unwell or concerned they should speak to their doctor."
http://www.ac.wwu.edu/~beu/info/news_articles/antiobesity_drug.html   (367 words)

  
 Scottish project gets backing for anti-obesity drug
There is a worldwide need for new, safe, drugs to be used at earlier stages to help manage obesity and prevent the need for large numbers of drugs for secondary conditions, as well as a lot of suffering."
He continued:“Optimal medical care, through the NHS, needs to include appropriate drug treatment and even surgery for some cases.
We need first of all to understand how this drug works and secondly to produce more powerful derivatives which will be safe and effective when taken by obese people."
http://www.nutraingredients.com/news/printNewsBis.asp?id=36850   (555 words)

  
 Obesity medications - drug therapy for obesity treatment
One form of this drug is found in the Chinese plant ma huang and is sold without a doctor's prescription.
- Obesity is a condition in which the natural energy reserve of a mammal.
Obesity medications - drug therapy for obesity treatment
http://mens-health.health-cares.net/obesity-medications.php   (1046 words)

  
 Bestselling author Michael Fumento reports: "Anti-Obesity Drug Is Heavy on Hype."
Medical literature is replete with instances of drugs that cured or killed rodents yet had no effect on humans.
But alas, what truly ails this nation no drug is going to cure.
Leptin won't strengthen the lungs, heart, and other muscles grown soft through too many hours of watching Home Improvement and Roseanne.
http://www.fumento.com/fatdrug.html   (949 words)

  
 Meridia
In such people, a drug which raises blood pressure and pulse could trigger angina, so anyone who experiences chest pain on Meridia should be advised to stop the drug (Chase, B1)".
Although Meridia and fenfluramine have similar mechanisms of action (they both affect serotonin), fenfluramine boosts the levels of serotonin into the blood stream.
This includes prescription drugs, over- the- counter medicines, and herbal products;
http://www.vanderbilt.edu/AnS/psychology/health_psychology/Meridia.htm   (2821 words)

  
 Anti-cholesterol drug 'lifesaver'
“This study shows that statin drugs could be beneficial in a much wider range of patients than is currently considered for treatment,” said Anthony Keech, deputy director of the NHMRC Clinical Trials Centre.
THOUSANDS of Heart Attacks and Strokes could be prevented if more Australians had access to cholesterol-lowering drugs.
“Of all drugs that I am aware of, Statins have the best safety record of any class of drug.”
http://www.dental.am/ldl-cholesterol/18692_0_23_0_C   (585 words)

  
 USATODAY.com - Anti-obesity drug gets first shot at OTC
Heightened concern about drug safety in this post-Vioxx era means the slightest hint of a problem would be enough to prevent Xenical from going OTC, Francesco says.
Maker Merck failed to show that consumers properly could decide on their own whether to take the drug, panelists said.
The USA has no such "behind-the-counter" drug category.
http://usatoday.com/news/health/2005-12-14-xenical-obesity-usat_x.htm?csp=34   (505 words)

  
 Guardian Anti-obesity drug available on NHS
The controversial anti-obesity drug Orlistat should be prescribed on the NHS, a government body ruled today.
Professor Peter Littlejohns, clinical director of Nice, said: "Today's guidance is another example of how Nice can help doctors and patients be clear about the value and appropriate use of a new medicine.
"Obesity has a major impact on a person's physical, social and emotional wellbeing and future health.
http://www.guardian.co.uk/print/0,3858,4149215-103690,00.html   (341 words)

  
 Meridia, anti obesity drug
Meridia is an outstanding anti-obesity drug used for medication in the US.
Based on research Meridia this is the most effective anti-obesity drug available on the market.
This anti-obesity drug is used to reduce excess body weight (obesity).
http://www.jzw.com.au/nutri/eprescribe/meridia/p1.html   (129 words)

  
 Drug Development Technology - Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
The promising preclinical findings with Acomplia (rimonabant) have been confirmed in a series of clinical studies, including pivotal phase III trials involving over 6,000 obese subjects that were carried out in both the US and Europe.
In the prevailing market there is a clear opportunity for an effective and well tolerated antiobesity drug.
The drug also has potential as a treatment for smoking cessation because the endocannabinoid system is also involved in the body's response to tobacco dependence.
http://www.drugdevelopment-technology.com/projects/rimonabant   (957 words)

  
 Xenical, the anti-obesity drug - anagrams
Find anagram aliases of xenical, the anti-obesity drug (or any other text)!
Find gold service anagrams of xenical, the anti-obesity drug (or any other text)!
"The anti-impotency drug Viagra" -> "Inept guy harmed 'virgo intacta'.
http://www.anagramgenius.com/archive/xenica.html   (103 words)

  
 Meridia, anti obesity drug, appetite suppressant
Over time, this medication may not work as well as it did at the beginning.
Also, if used for a longer period of time, do not suddenly stop using this drug without your doctor's approval.
Elderly patients may be more sensitive to the effects of this drug.
http://www.grubas.com/meridia/meridia.htm   (404 words)

  
 Datamonitor Research Reports -- Commercial and Pipeline Perspectives: Obesity - Super-sized Epidemic
Table 30: Breakdown of the anti-obesity pipeline by type of therapy, 2004
Table 12: US anti-obesity drug sales from 1999-2003
Figure 23: Comparative sales forecasts for the key therapies in the anti-obesity drug market, 2003-12
http://www.nhionline.net/products/datamonitormr50.htm   (851 words)

  
 Gulfnews: Anti-obesity drug's positive review hailed
A Dubai endocrinologist has hailed the positive review of the anti-obesity drug Sibutramine by the European Union's Committee for Proprietary Medicinal Prod-ucts (CPMP).
The CPMP's analysis represents the outcome of extensive scientific review of data by the 15 European member states.
These studies analysed the use of Sibutramine in more than 12,000 obese patients.
http://archive.gulfnews.com/articles/02/07/10/57162.html   (311 words)

  
 anti obesity drug - welcome to anti obesity drug
Drug Recall News provides up-to-date information about drugs that have been recalled by the FDA or problems with drugs.
News, information, and resources on drug and alcohol rehabilitation.
Free consultation with every order of Drugstore Prescriptions! No prior prescription is necessary to order from the on line drug store. Buy your prescription online today!
http://www.obesitypr.com/antiobesitydrug   (2104 words)

  
 BBC News HEALTH Anti-obesity drug 'works well'
Scientists have carried out a major study into the impact of the drug on thousands of volunteers.
The new research, the largest of its kind, focused on more than 15,000 overweight men and women in Germany.
It showed that on average patients lost 11% of their bodyweight after taking the drug for seven months.
http://news.bbc.co.uk/hi/english/health/newsid_1363000/1363698.stm   (526 words)

  
 anti-diabetic drug: Information From Answers.com
Four, known as "first-generation" drugs, have been in use for some time, but not all remain available.
anti-diabetic drug is mentioned in the following topics:
Meaning #1: a drug used to treat diabetes mellitus
http://www.answers.com/topic/anti-diabetic-drug   (810 words)

  
 Anti-Obesity Drug Shows Promise in UAB Study
The multi-center study, which included researchers at UAB (University of Alabama at Birmingham), is the largest and longest of any double-blind placebo-controlled trial designed to test the efficacy of any weight-loss medication in obese patients.
This study shows that Xenical has a beneficial effect on both of these endpoints, thereby improving patient’s overall health.”
However, as with other medications developed for treating obesity, Xenical will not prevent the need for permanent lifestyle change, according to Heimburger.
http://main.uab.edu/show.asp?durki=8082   (618 words)

  
 [No title]
The largely optimistic numbers posted in the latest study conducted by Sanofi-Aventis were just as superficially impressive: 40 percent of the patients monitored lost three times as much weight as those on a placebo.
Even though the results of that study sounded surprisingly upbeat, the lead researcher pointed out, as I do here all the time on my Web site, taking a drug is no substitute for making the necessary lifestyle changes to optimize your health.
You may recall a study I posted late last fall about rimonabant, touted to be the latest cure-all drug for obesity.
http://www.mercola.com/blog/2005/mar/8/antiobesity_drug_no_cureall   (504 words)

  
 drug obesity Dy Obesity
Ph.D. has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side...
Video Pictures Home YOU ARE HERE: Home > News > Health > Article advertisement Arena obesity drug proves effective in short study Wed May 11, 2005 10:05 AM ET Printer Friendly
Obesity drug 'may fight cancer' A drug currently used to treat obesity may also be able to fight prostate cancer, a study suggests.
http://www.dyobesity.com/2/drugobesity   (701 words)

  
 Arena Pharmaceuticals Initiates Clinical Trial of Novel Anti-Obesity Drug
If the Phase 1 clinical trial is successful, the company anticipates launching a Phase 2 clinical trial in overweight and obese patients in 2005.
Arena's in vivo experiments showed that APD356 selectively reduced fat mass in obese animals, while leaving lean body mass unchanged, a very desirable outcome.
Arena is a biopharmaceutical company seeking to discover and develop drugs that act on an important class of drug targets called G protein-coupled receptors, or GPCRs.
http://www.freshnews.com/news/biotech-biomedical/article_16930.html   (1140 words)

  
 ScienceDaily: "Fat-Proof" Mice Yield New Anti-Obesity Drug Target
Because these drugs are intended to alter one of the fundamental processes of the human body,...
Anti-obesity drug -- Anti-obesity drugs include all pharmacological treatments intended to reduce or control weight.
According to Chan, drugs that disrupt a very precise target like perilipin in body tissues have potentially fewer side effects than those affecting the brain or multiple organ systems.
http://www.sciencedaily.com/releases/2000/11/001129074413.htm   (1035 words)

  
 Guardian Two patients die after taking anti-obesity drug
The Department of Health said it had no plans to take the drug out of circulation, arguing that the deaths may be related to the patients' underlying health problems.
Doctors are able to prescribe Reductil to patients who are seriously overweight as part of a strategy to tackle their problem that would include a calorie controlled diet.
Two patients prescribed a new anti-obesity drug by their GPs have died, the Department of Health revealed last night.
http://www.guardian.co.uk/print/0,3858,4375586-110418,00.html   (215 words)

  
 HealthScout-Consumer Health News, Information and Resources Updated Daily-Liver-Liver Protein Points to Anti-Obesity ...
The finding could lead the way to new anti-obesity drugs, researchers say.
To find more information on specific conditions, please visit our partner sites:
TUESDAY, April 12 (HealthDay News) -- A liver protein already well known for its role in regulating cholesterol may also help the body pack on unwanted fat, new research suggests.
http://www.healthscout.com/news/1/525080/main.html   (325 words)

  
 Abbott cuts 2002 outlook - Jun. 11, 2002
Drugmaker attributes lower guidance to plant quality problems, slower anti-obesity drug sales.
ABBOTT PARK, Ill. (Reuters) - Abbott Laboratories Inc. cut is second-quarter and 2002 earnings outlook Tuesday, citing manufacturing problems at an Illinois plant and slower sales of an anti-obesity drug.
The company also cited slowing sales of prescription anti-obesity drug Meridia/Reductil, which was pulled from some markets in Europe due to safety concerns.
http://money.cnn.com/2002/06/11/news/companies/abbott.reut   (307 words)

  
 Anti-clotting drug cuts heart attack deaths
About 20 million people survive Heart attack and stroke each year but many require long-term care.
The drug is complementary to aspirin but works in a different way.
The British Health Foundation said the research is the latest of several studies showing the benefits of the drug for patients with vascular disease.
http://www.3-rx.com/ab/more/anti_clotting_drug_cuts_heart_attack_deaths   (510 words)

  
 Anti-obesity drug sibutramine (Reductil) Q&As
Anti-obesity drug sibutramine (Reductil) Q&As Anti-obesity drug sibutramine (Reductil) QandAs
Obesity has a major impact on a person’s physical, social and emotional wellbeing.
Sibutramine (Reductil) is a drug treatment to help those who are obese to lose weight.
http://www.diabetes.org.uk/infocentre/inform/sibutramine.htm   (667 words)

  
 auser,Introducing HGH: The Most Powerful Anti-Obesity Drug Ever
Subject: auser,Introducing HGH: The Most Powerful Anti-Obesity Drug Ever
auser,Introducing HGH: The Most Powerful Anti-Obesity Drug Ever
http://www.arkeia.com/archives_indexed/2002/05/msg00131.html   (72 words)

  
 CNN - Anti-obesity drug to get warning label - August 22, 1996
Stuart Rich, a cardiologist at the University of Illinois Medical Center and an American author of the study, said that even the revised numbers do not adequately describe the risks of taking the drug.
Rich said he is worried the drug will be used by people who are just a few pounds overweight when it should only be prescribed to those who are obese.
He said one of the reasons the risk increased under the new study is because earlier research was based on patients who used the drug for three months.
http://www.cnn.com/HEALTH/9608/22/weight.drug   (435 words)

  
 Metabolic opens bidding for anti-obesity drug - Business - www.theage.com.au
The drug could be on the market by late 2008.
The Melbourne-based biotech yesterday announced that its phase IIb clinical study had shown the drug effectively induced weight loss in obese patients, paving the way for a pivotal phase III study to begin next year.
Comparing the weight loss in the placebo group to that achieved by the group taking a 1 milligram dose of Metabolic's drug, there was a 10 per cent chance that the positive result could have been caused by factors other than AOD9604.
http://www.theage.com.au/news/Business/Metabolic-opens-bidding-for-antiobesity-drug/2004/12/13/1102787015399.html   (603 words)

  
 Obesity Drug Helps Maintain Weight Loss
We should not give (anti-obesity treatment) to all our patients," said Astrup.
More than a 10% weight loss was achieved and maintained by 37% of patients on active treatment compared with 19% of placebo patients.
And the researcher recommends that the dose of anti-obesity drug therapy be occasionally reduced or discontinued "to see if the patient can maintain weight loss....
http://www.personalmd.com/news/a1999060412.shtml   (486 words)

  
 Meridia obesity drug side effects
Last December, Britain's Drug and Therapeutics Bulletin, published by the Consumers' Association, which warned the weight-loss drug had limited benefits and ``unwanted'' side effects.
The drug has been linked to serious side effects which include: rapid heart rate, increased blood pressure, heart disease, stroke, seizure and mental impairments.
Althought Italy was the first country to take the drugs off the market other nation's regulatory bodies have expressed concern about sibutramine.
http://www.meridia-side-effects.com   (223 words)

  
 Hopes rise for experimental anti-obesity drug - Diet & Fitness - MSNBC.com
Acomplia offers a novel approach to tackling two factors -- obesity and smoking -- that are responsible for many heart attacks and strokes.
Results of two earlier studies have shown that around 40 percent of patients who stay on Acomplia for a year lose more than 10 percent of their body weight.
The drug also boosts levels of “good” HDL cholesterol in the blood.
http://www.msnbc.msn.com/id/6414716   (459 words)

  
 Shares in Sanofi fall after anti-obesity drug setback
The use of Rimonabant as an anti-smoking treatment is minor compared with its potential as an anti-obesity drug, analysts said.
Investors were reacting to news that the US Food and Drug Administration had written to the company to demand additional information before approving its drug Rimonabant as an anti-obesity treatment.
In a second letter, the FDA had ruled out the use of Rimonabant in its present form as an anti-smoking treatment, which was seen as another potential use of the drug.
http://www.turkishpress.com/news.asp?id=108877   (346 words)

  
 Anti-obesity drug wins FDA panel's recommendation
Xenical may work by causing ''a kind of intestinal aversion,'' said Dr. Jules Hirsch of Rockefeller University, before joining scientific advisers to the Food and Drug Administration in recommending approval of the drug.
Xenical, known chemically as orlistat, would become the first drug to fight obesity through the intestine instead of the brain.
But scientists cautioned that Xenical, a prescription drug, comes with embarrassing side effects that worsen with the more fat that dieters eat.
http://www.lubbockonline.com/news/051597/anti.htm   (303 words)

  
 New anti-obesity drug hits U.S. market
The drug orlistat has been approved for sale in the U.S. Orlistat works by blocking fat absorption in the intestine.
A recent study found that those on the drug lost an average of 19 pounds versus those on the placebo who lost 13 pounds.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
http://www.biomed.lib.umn.edu/hmed/1999/04/19990427_aob.html   (136 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.